Post-IPO Equity Therapeutics Companies

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.

Stimcell Energetics is a biotechnology company that focuses on the discovery, development, and commercialization of therapeutic products.

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

Greenbrook provides Transcranial Magnetic Stimulation (TMS) therapy for individuals with treatment-resistant depression.

NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.

Carbiotix is a pre-clinical stage therapeutics company focusing on low-cost gut health testing and microbiome modulators.

Numinus utilizes psychedelic-assisted psychotherapy methods to bring holistic healthcare to patients.

Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.

Better Therapeutics develops prescription software for treating cardiometabolic diseases.

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders.

Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.